RMM Grants Awarded

See where grants have been awarded across Minnesota.
Erik Finger, MD, PhD
One potential cure for diabetes is the transplantation of pancreatic islets—insulin secreting clusters of cells that reside within the pancreas.…
2019-2021
Deborah Ferrington, PhD
Age-related macular degeneration (AMD) is a chronic disease that causes central vision loss and affects one's ability to read, drive, and recognize…
2019-2021
Veena Taneja, PhD
We have generated a novel expeditious model of cigarette smoke-induced COPD in mice that expresses human immune genes and mimics human immune…
2019-2021
Bhairab Singh, PhD
Cardiovascular disease in the number one cause of death worldwide and it is the most common cause of death in the United States. This grant…
2019-2021
Jacob Montgomery, PhD
Spinal cord injury often leads to loss of function below the injury, greatly reducing patient life expectancy and quality and, because the human…
2019-2021
Mi-Hyeon Jang, PhD
In the United States, cognitive dysfunction stemming from chemotherapy (chemobrain) is a major adverse condition affecting approximately 14 million…
2019-2021
Wenqian Hu, PhD
A major problem in leukemia treatment is the rise of drug-resistant mutations in the genome of cancer cells, which makes many well-designed cancer…
2019-2021
Leigh Griffiths, DVM, PhD
Minnesota Department of Health statistics indicate that almost 100,000 Minnesotan’s are currently affected by ischemic heart disease (IHD),…
2019-2021
Jonathan Finnoff, DO
Musculoskeletal injuries and diseases are the main cause of disability in the U.S. Platelet Rich Plasma (PRP) is defined as an autologous blood…
2019-2021
LaTonya Hickson, MD
Diabetic kidney disease (DKD) is the most common cause of kidney failure in the U.S. and has no adequate cure. Mesenchymal stromal cell (MSC)…
2019-2021
Anna Wirta Kosobuski, EdD
Sites: Multiple Bois Forte Band of Chippewa - Nett Lake Elementary School Grand Portage Band of Lake Superior Chippewa - Oshki Ogimaag Community…
2018-2019
Timothy D. O'Brien, DVM, PhD
Our overall goal is to develop a cell therapy product for the treatment of Parkinson's disease.  In the present proposal we will evaluate…
2018-2019